English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
Revenue and EBITDA Supported by Strong Q2 Growth in the First Half of the Year 2026 Guidance Confirmed
2026-08-03
Original from: Diasorin The Board of Directors of Diasorin S.p.A. (FTSE MIB: DIA) meeting today, examined and approved the Group’s Consolidated Financial Statements at June 30, 2026. ..
Siemens Healthineers shows strong order momentum; full-year growth expectations lowered and earnings forecast raised
2026-08-03
Original from: Siemens Healthineers Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2026 ended June 30, 2026. Q3 Fiscal Year 2026 • Outs..
Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
2026-07-31
Original from: Guardant Health Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended June 30, 2026. Second Quarter..
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
2026-07-31
Original from: Illumina Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 res..
Intelligenome, Cornell Partner on Portable TB Diagnostic
2026-07-30
Original from: RESPIRATORY THERAPY Intelligenome and Cornell University entered into a research and development subaward agreement to support the development of a rapid, low-cost, and portable diagnostic..
Alveo Technologies Partners with University of Texas Medical Branch (UTMB) to Develop Point-of-Care Diagnostics for Lassa Fever in West Africa
2026-07-30
Original from: PR Newswire Alveo Technologies, Inc. (Alveo), a leader in portable molecular sensing solutions, today announced a strategic partnership with The University of Texas Medical Branch (UTMB) t..
bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
2026-07-29
Original from: bioMérieux bioMérieux, a world leader in the field of in vitro diagnostics, today announces the submission of the BIOFIRE® FILMARRAY® Gastrointestinal 1.1 (GI1.1) Panel and the B..
In Vitro Diagnostic Industry in China - Urine V
2026-07-28
2.2.2 H-1600 Automatic Urine Dry Chemistry Analyzer Produced by DIRUI, it can meet the needs of intelligent, automated, and high-throughput urine dry chemical test in hospitals. 1. Structure: It co..
Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
2026-07-28
Original from: Waters The Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Meeting — Waters Corporation (NYSE: WAT) today announced the launch of the Xevo TQ Absolute XR IVD Mass..
FDA approves Freenome's blood test for colorectal cancer screening
2026-07-28
Original from: Reuters The U.S. FDA has approved Freenome's (FRNM.O), opens new tab blood-based colorectal cancer screening test for older adults, paving the way for partner Abbott (ABT.N), opens ..
IVD China last week: WEGO Life Science, YHLO✖️Peking University, URIT, MGI✖️Wuliangye Technology, Haier Biomedical✖️Addison,
2026-07-27
WEGO Life Science and Pakistan’s LDS Sign Local Manufacturing Agreement to Advance IVD Collaboration WEGO Life Science has signed a localisation production agreement with Pakistan-based L..
Ibex Medical Analytics Achieves CE-IVDR Certification for Breast Panel IHCs, Elevating the Standard of Care in AI-Powered Breast Cancer Diagnostics
2026-07-27
Original from: Ibex Medical Analytics Ibex Medical Analytics (Ibex), the global leader in AI-powered pathology solutions for clinical diagnostics and biopharma, today announced that it has received In Vi..
Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis
2026-07-27
Original from: Roche Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its cobas® BV/CV (Bacterial vaginosis/Candid..
Thermo Fisher Scientific Reports Second Quarter 2026 Results
2026-07-24
Original from: Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 27, 2026. ..
Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
2026-07-24
Original from: Roche - Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the first six months, driven by high demand for innovative medicines and diagno..
Total:
3839
Pages:
256
First
Prev
1
2
3
4
..
256
Next
End